Oraianthi Fiste - Publications

The Prognostic Role of Different Blood Cell Count-to-Lymphocyte Ratios in Patients with Lung Cancer at Diagnosis.

Journal: Cancers

Published: November 02, 2025

Persistent Liver Manifestations in Allopurinol-Induced Sweet's Syndrome: An Uncommon Case Report.

Journal: Journal of clinical medicine

Published: August 10, 2025

Editorial: PARP inhibitors resistance: new insights in ovarian cancer therapy.

Journal: Frontiers in oncology

Published: August 06, 2025

AΙ-Driven Drug Repurposing: Applications and Challenges.

Journal: Medicines (Basel, Switzerland)

Published: July 25, 2025

Serum Proteomics of Ribociclib-Mediated Cardiovascular Toxicity: An Exploratory Case-Control Study.

Journal: Proteomics. Clinical applications

Published: February 14, 2025

Inflammation-related biomarkers as predictors of pathological complete response in early-stage breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 12, 2024

Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group.

Journal: Journal of geriatric oncology

Published: August 23, 2024

A rare case of Takotsubo cardiomyopathy.

Journal: European review for medical and pharmacological sciences

Published: March 18, 2024

Emerging Therapies in Kirsten Rat Sarcoma Virus (+) Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: February 27, 2024

Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or Relapse.

Journal: Cancers

Published: February 14, 2024

Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC.

Journal: Cancers

Published: January 31, 2024

Cardiovascular complications of ribociclib in breast cancer patients.

Journal: Critical reviews in oncology/hematology

Published: October 02, 2023